Skip to main content
Clinical Trials/NCT03133091
NCT03133091
Completed
Phase 3

Epidural Analgesia During Labour Randomized Clinical Trial Comparing Patient Controlled Epidural Analgesia Versus Patient Intermittent Epidural Boluses With Levobupivacaine

Hospital del Río Hortega1 site in 1 country200 target enrollmentSeptember 2015

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Anesthesia, Obstetrical
Sponsor
Hospital del Río Hortega
Enrollment
200
Locations
1
Primary Endpoint
VAS
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

Randomized single blind trial based on comparing the way the local anesthetic is dosificated during labour. The pain control is evaluated and compared with both dosage techniques (PCEA vs PIEB)using levobupivacaine and fentanyl. The primary objective is to see no differences in pain control(VAS, Visual Analog Scale). The secondary goals are the differences in motor block(Bromage Scale), satisfaction (Likert Scale), the outcome (eutocic, instrumental o cesarean section), second stage of labour time, newborn´s Apgar and pH and total dosis and secondary effects of local anesthetic.

Detailed Description

There is a protocol where every healthy primiparous women have the chance to join the study after the explanation and the informed consent is signed. There are blind envelopes with the two kinds of treatment and the investigator only has to follow the protocol.

Registry
clinicaltrials.gov
Start Date
September 2015
End Date
September 2017
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Hospital del Río Hortega
Responsible Party
Principal Investigator
Principal Investigator

MARIA BELEN RODRIGUEZ-CAMPOO

PhD title in Medicine and Surgery

Hospital del Río Hortega

Eligibility Criteria

Inclusion Criteria

  • 20- 40 years-old women
  • Primiparous women
  • Dilatation 3- 7 cm
  • No risk illnesses for epidural block
  • No risk pregnancy
  • Signed informed consent

Exclusion Criteria

  • Illnesses which are a risk for pregnancy
  • Multiparous women
  • Contraindicated diseases for epidural block
  • Women who can not understand the procedure
  • Women who do not want to sign the informed consent
  • Patients with drug´s allergy

Outcomes

Primary Outcomes

VAS

Time Frame: 4 times after epidural block: previous, 1 hour after, 2 hours after, 15 minutes after delivery

Change from baseline in Visual Analog Scale

Secondary Outcomes

  • Bromage Scale(15 minutes after Epidural Block and 1 hour after epidural block)
  • Labour Outcome(Delivery)
  • Apgar at birth(5 minutes after birth)
  • fetal pH at birth(0 minutes after delivery)
  • Satisfaction (Likert Scale)(1 hour after delivery)
  • Expulsive time(From 10 cm of dilatation until delivery)
  • Total Dosis of Levobupivacaine(0 minutes after delivery)

Study Sites (1)

Loading locations...

Similar Trials